Interra Health is a US-based healthcare technology company formed in March 2026 through the merger of DoseSpot and Arrive Health, incorporating pVerify's capabilities. The company provides technology connecting electronic prescribing, insurance eligibility verification, prescription benefit information, medication pricing, prior authorization, and pharmacy access. Its products include DoseSpot ePrescribing, pVerify eligibility verification, and Arrive Health's real-time prescription benefit solutions. The platform integrates with healthcare applications to help clinicians identify covered medications, compare costs, manage authorization requirements, and provide patients with pharmacy options. Interra Health serves healthcare providers, health systems, health technology companies, health plans, pharmacy benefit managers, and life sciences organizations. Its technology addresses fragmented prescribing workflows, medication affordability challenges, administrative delays, and barriers to treatment access.
Interra Health offers opportunities to develop healthcare software addressing medication affordability, prescription access, and administrative complexity. Formed through the 2026 merger of DoseSpot and Arrive Health, the company is backed by Bain Capital Tech Opportunities and other investors. It reports supporting approximately 800,000 healthcare providers and processing nearly 350 million electronic prescribing transactions annually. Engineering roles involve cloud-native applications, high-volume transaction processing, healthcare integrations, and technologies including .NET, React, SQL Server, and Microsoft Azure. The company was recognized in the Boston Business Journal's 2026 Best Places to Work program. Its careers page describes remote-first opportunities in the US and India, flexible scheduling, health benefits, retirement benefits, and paid leave. Benefits vary by location, and candidates should consider the ongoing integration of the merged businesses.
Programming Language
Backend Framework
Frontend Framework
Programming Language
Programming Language
Database
Cloud Infrastructure
Cloud Application Hosting
Serverless Computing
Event-Driven Infrastructure
Cloud Storage
React UI Library
Monorepo Development Tools
Development and CI/CD
Josh Weiner became CEO of Interra Health following the merger of DoseSpot and Arrive Health in March 2026. Previously, he served as CEO of DoseSpot and Solutionreach, a healthcare patient engagement software company. He also spent six years as an Operating Partner at Summit Partners and began his career at McKinsey & Company. A Stanford University graduate, he leads Interra Health's business strategy, integration, and growth.
Ruksi Gregory oversees operations at Interra Health. Previously, she was COO of DoseSpot and Vice President of Growth Operations at InStride Health. At athenahealth, she worked across business development, product strategy, revenue cycle management, and operational improvement. She holds an MBA from Harvard Business School and an engineering degree from the University of Michigan. Her experience includes scaling healthcare operations and improving administrative workflows.
Michelle Kohut leads technology and engineering at Interra Health. Previously, she served as CTO of DoseSpot and held technology leadership responsibilities at Claricode, a healthcare software development company. Her background includes software engineering, electronic prescribing, healthcare applications, and platform architecture. She studied at La Salle University and Johns Hopkins University.
Christie Callahan leads product strategy and development at Interra Health. Previously, she was Chief Operating Officer of Arrive Health, working on medication affordability, real-time prescription benefits, and electronic prior authorization. Earlier, she served as Vice President of Strategy and Innovation at CVS Health and worked at Bain & Company. Her expertise includes healthcare interoperability, pharmacy operations, product strategy, and process improvement.
Tosin Adesegha oversees financial strategy and operations at Interra Health. Previously, he served as CFO of DoseSpot and held senior finance responsibilities at Pathstream. His earlier experience includes investment banking at Goldman Sachs and Barclays. He studied at Columbia Business School. His expertise includes financial planning, investor relations, corporate finance, and business operations.
Adam Gail leads revenue generation, enterprise sales, and commercial strategy at Interra Health. Previously, he held revenue leadership roles at DoseSpot, Stellar Health, and RubiconMD. His background includes healthcare technology sales, commercial team development, customer relationships, and go-to-market strategy. He studied at the University of Miami.
JB Powell leads business development and strategic partnerships at Interra Health. Previously, he founded and served as CEO of RxLink, which DoseSpot acquired in 2024. His experience includes healthcare technology partnerships, patient engagement, and medication access solutions. At Interra Health, he works on partnerships connecting healthcare providers, payers, pharmacies, and life sciences organizations.
Josh Latson serves as Chief of Staff at Interra Health. Previously, he worked at Boston Medical Center Health System in healthcare finance and organizational leadership. His experience includes strategic planning, operational coordination, and healthcare administration. At Interra Health, he supports executive coordination and strategic initiatives across the combined organization.
GlobeNewswire
Interra Health announced its selection as a quarterfinalist in the 2026 Digital Health & AI Awards in the Therapeutics, Pharmacy & Medication Innovation category. The recognition highlighted its work connecting medication affordability, prescribing, and pharmacy access.
Read articleGlobeNewswire
Interra Health announced support for the Medicare GLP-1 Bridge program, which provides eligible beneficiaries access to certain obesity medications for $50 per month. Its prescribing technology alerts clinicians when patients may qualify and provides information about diagnostic codes and prior authorization. The company reported delivering more than 170,000 alerts to over 30,000 prescribers during the program's first two months.
Read articleGlobeNewswire
Interra Health announced its inclusion in the 2026 Inc. 5000 list, reporting 107% revenue growth over the three-year measurement period. The company stated that its combined organization had approximately 200 employees, processed nearly 350 million electronic prescribing transactions annually, and supported approximately 800,000 healthcare providers. The growth figures relate to the predecessor businesses before their 2026 merger.
Read articleGlobeNewswire
Interra Health was recognized in the Boston Business Journal's 2026 Best Places to Work program. The recognition was based on confidential employee surveys covering engagement, management communication, work-life balance, compensation, and workplace satisfaction.
Read articleGlobeNewswire
DoseSpot and Arrive Health announced their merger to form Interra Health, combining electronic prescribing, prescription benefit transparency, pharmacy pricing, and insurance eligibility verification capabilities. Bain Capital Tech Opportunities led the investment supporting the transaction and became the majority owner. PSG retained a minority stake, while Providence and UPMC Enterprises also participated as minority investors. Josh Weiner was appointed CEO.
Read articleInterra HealthLocation not specified
